BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23935012)

  • 1. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.
    Quinlan DJ; Eikelboom JW; Weitz JI
    Circulation; 2013 Sep; 128(11):1179-81. PubMed ID: 23935012
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. 4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal.
    Lang E
    Ann Intern Med; 2014 Apr; 160(8):JC6. PubMed ID: 24733223
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
    Sarode R; Milling TJ; Refaai MA; Mangione A; Schneider A; Durn BL; Goldstein JN
    Circulation; 2013 Sep; 128(11):1234-43. PubMed ID: 23935011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin complex concentrates as reversal agents for new oral anticoagulants: lessons from preclinical studies with Beriplex.
    Dickneite G
    Clin Lab Med; 2014 Sep; 34(3):623-35. PubMed ID: 25168947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergent reversal of vitamin K antagonists: addressing all the factors.
    Martin DT; Barton CA; Dodgion C; Schreiber M
    Am J Surg; 2016 May; 211(5):919-25. PubMed ID: 27046797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
    Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M
    Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of four-factor prothrombin complex concentrate in the emergency department: a review.
    Willis CM; Hall AB
    J Emerg Nurs; 2015 Jan; 41(1):9-12. PubMed ID: 25016517
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of prothrombin complex concentrates in anticoagulation.
    van Veen SQ; Strengers PF
    Am J Hematol; 2008 Apr; 83(4):344-5. PubMed ID: 18213649
    [No Abstract]   [Full Text] [Related]  

  • 9. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.
    Pabinger I; Brenner B; Kalina U; Knaub S; Nagy A; Ostermann H;
    J Thromb Haemost; 2008 Apr; 6(4):622-31. PubMed ID: 18208533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding.
    Evans G; Luddington R; Baglin T
    Br J Haematol; 2001 Dec; 115(4):998-1001. PubMed ID: 11843839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose.
    Holland L; Warkentin TE; Refaai M; Crowther MA; Johnston MA; Sarode R
    Transfusion; 2009 Jun; 49(6):1171-7. PubMed ID: 19210325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombal: a new concentrate of human prothrombin complex for clinical use.
    Bruning PF; Loeliger EA
    Br J Haematol; 1971 Oct; 21(4):377-98. PubMed ID: 5001176
    [No Abstract]   [Full Text] [Related]  

  • 13. Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal: Does One Dose Fit All?
    Schwebach AA; Waybright RA; Johnson TJ
    Pharmacotherapy; 2019 May; 39(5):599-608. PubMed ID: 30892733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence.
    Sarode R
    Clin Lab Med; 2014 Sep; 34(3):613-21. PubMed ID: 25168946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human prothrombin complex.
    N Engl J Med; 1965 Sep; 273(13):715-6. PubMed ID: 5827038
    [No Abstract]   [Full Text] [Related]  

  • 16. [Attempted suicide with super warfarin].
    Rodrigo Casanova P; Rodríguez Fernández V; García Peña JM; Aguilera Celorrio L
    Rev Esp Anestesiol Reanim; 2005 Oct; 52(8):506-7. PubMed ID: 16281750
    [No Abstract]   [Full Text] [Related]  

  • 17. Beriplex--the new generation haemorrhage stopper.
    Nandanan S; Goel R
    J Obstet Gynaecol; 2010; 30(8):872-3. PubMed ID: 21126138
    [No Abstract]   [Full Text] [Related]  

  • 18. Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital.
    Bruce D; Nokes TJ
    Crit Care; 2008; 12(4):R105. PubMed ID: 18706082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin complex concentrate (Beriplex P/N).
    Scott LJ
    Drugs; 2009 Oct; 69(14):1977-84. PubMed ID: 19747012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
    O'Leary DS; Ruymann FB; Conrad ME
    J Lab Clin Med; 1971 Jan; 77(1):23-32. PubMed ID: 5540427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.